{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:56:20Z","timestamp":1793141780001,"version":"4.5.0"},"reference-count":144,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"unspecified","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["CRC\/TR 412 (Project-ID 535081457)"],"award-info":[{"award-number":["CRC\/TR 412 (Project-ID 535081457)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["SFB1382 (Project-ID 403224013)"],"award-info":[{"award-number":["SFB1382 (Project-ID 403224013)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["Ta434\/8-1"],"award-info":[{"award-number":["Ta434\/8-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["egastro"],"accepted":{"date-parts":[[2025,10,31]]},"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>In vitro liver disease modelling, a rapidly evolving field, has become a multidimensional endeavour aimed at more precisely and effectively recapitulating the complexity of hepatic pathophysiology. This review systematically outlines the essential structural and cellular components of the liver as foundational elements for model design. Emphasising pathophysiological states rather than disease hallmarks, we discuss key liver injury paradigms, including hepatic steatosis, drug-induced hepatotoxicity, fibrogenesis, tumourigenesis and cholestatic injury. Each section integrates cellular mechanisms with model development strategies, highlighting advances in co-culture systems, multicellular organoids and liver-on-a-chip platforms. Although challenges persist, emerging platforms are increasingly capable of capturing multicellular crosstalk, structural heterogeneity and injury-response dynamics. Moving forward, model utility will depend not only on structural mimicry but on the ability to produce biologically meaningful outputs under experimentally controlled conditions.<\/jats:p>","DOI":"10.1136\/egastro-2025-100279","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T19:50:12Z","timestamp":1764359412000},"page":"e100279","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Engineering liver disease models in vitro: emerging trends and innovations"],"prefix":"10.1136","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9087-4224","authenticated-orcid":false,"given":"Qi","family":"Rao","sequence":"first","affiliation":[{"name":"Institute of Chemistry and Biochemistry, Freie Universit\u00e4t Berlin, Berlin, Germany"},{"name":"Department of Hepatology & Gastroenterology, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8005-277X","authenticated-orcid":false,"given":"Lei","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Chemistry and Biochemistry, Freie Universit\u00e4t Berlin, Berlin, Germany"},{"name":"Institute of Functional Materials for Sustainability, Helmholtz-Zentrum Hereon, Teltow, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6206-0226","authenticated-orcid":false,"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[{"name":"Department of Hepatology & Gastroenterology, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6002-9986","authenticated-orcid":false,"given":"Adrien","family":"Guillot","sequence":"additional","affiliation":[{"name":"Department of Hepatology & Gastroenterology, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4006-1003","authenticated-orcid":false,"given":"Nan","family":"Ma","sequence":"additional","affiliation":[{"name":"Institute of Chemistry and Biochemistry, Freie Universit\u00e4t Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"2025112811500643000_3.4.e100279.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.017"},{"key":"2025112811500643000_3.4.e100279.2","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11427-024-2722-2","article-title":"Epidemiology of liver diseases: global disease burden and forecasted research trends","volume":"68","author":"Xiao","year":"2025","journal-title":"Sci China Life Sci"},{"key":"2025112811500643000_3.4.e100279.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.04.015"},{"key":"2025112811500643000_3.4.e100279.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2024.02.007"},{"key":"2025112811500643000_3.4.e100279.5","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00759-2"},{"key":"2025112811500643000_3.4.e100279.6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jcmgh.2022.11.008","article-title":"In Vitro Models for the Study of Liver Biology and Diseases: Advances and Limitations","volume":"15","author":"Kaur","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2025112811500643000_3.4.e100279.7","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028902","article-title":"What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? The Importance of Bridging Studies and Species-Independent Correlates of Protection","volume":"10","author":"Golding","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2025112811500643000_3.4.e100279.8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313135","article-title":"The Curious Case of the HepG2 Cell Line: 40 Years of Expertise","volume":"22","author":"Arzumanian","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025112811500643000_3.4.e100279.9","doi-asserted-by":"crossref","first-page":"102647","DOI":"10.1016\/j.clinre.2025.102647","article-title":"Hepatic organoids as a platform for liver disease modeling and the development of novel therapies","volume":"49","author":"Luce","year":"2025","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2025112811500643000_3.4.e100279.10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jhep.2024.01.002","article-title":"Organoid-guided precision hepatology for metabolic liver disease","volume":"80","author":"Osonoi","year":"2024","journal-title":"J Hepatol"},{"key":"2025112811500643000_3.4.e100279.11","unstructured":"Liver circulation and function. Available: https:\/\/journals.physiology.org\/doi\/epdf\/10.1152\/physrev.1963.43.1.115 [Accessed 12 May 2025]."},{"key":"2025112811500643000_3.4.e100279.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-025-01050-2"},{"key":"2025112811500643000_3.4.e100279.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.05.014"},{"key":"2025112811500643000_3.4.e100279.14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev-pathmechdis-031521-024831","article-title":"Spatiotemporal Metabolic Liver Zonation and Consequences on Pathophysiology","volume":"18","author":"Martini","year":"2023","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"2025112811500643000_3.4.e100279.15","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000491","article-title":"Liver macrophages revisited: The expanding universe of versatile responses in a spatiotemporal context","volume":"8","author":"Guillot","year":"2024","journal-title":"Hepatol Commun"},{"key":"2025112811500643000_3.4.e100279.16","doi-asserted-by":"crossref","unstructured":"Chen L , Guillot A , Tacke F , et al . Reviewing the function of macrophages in liver disease. Expert Review of Gastroenterology &Amp; Hepatology 2025;621\u201337. doi:10.1080\/17474124.2025.2508963","DOI":"10.1080\/17474124.2025.2508963"},{"key":"2025112811500643000_3.4.e100279.17","doi-asserted-by":"crossref","DOI":"10.3390\/bioengineering10020131","article-title":"Primary Hepatocyte Isolation and Cultures: Technical Aspects, Challenges and Advancements","volume":"10","author":"Kaur","year":"2023","journal-title":"Bioengineering (Basel)"},{"key":"2025112811500643000_3.4.e100279.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.06.030"},{"key":"2025112811500643000_3.4.e100279.19","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s00424-021-02622-2","article-title":"The bile acid-sensitive ion channel (BASIC) mediates bile acid-dependent currents in bile duct epithelial cells","volume":"473","author":"Wiegreffe","year":"2021","journal-title":"Pflugers Arch - Eur J Physiol"},{"key":"2025112811500643000_3.4.e100279.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07465-2"},{"key":"2025112811500643000_3.4.e100279.21","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000207"},{"key":"2025112811500643000_3.4.e100279.22","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-00411-3"},{"key":"2025112811500643000_3.4.e100279.23","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s42255-021-00501-9","article-title":"Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity","volume":"3","author":"Tilg","year":"2021","journal-title":"Nat Metab"},{"key":"2025112811500643000_3.4.e100279.24","doi-asserted-by":"publisher","DOI":"10.1016\/J.IMMUNI.2022.08.002"},{"key":"2025112811500643000_3.4.e100279.25","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-025-01068-6"},{"key":"2025112811500643000_3.4.e100279.26","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1016\/j.jhep.2024.02.001","article-title":"Systemic metabolic abnormalities: Key drivers of complications and mortality in MASLD","volume":"80","author":"Fan","year":"2024","journal-title":"J Hepatol"},{"key":"2025112811500643000_3.4.e100279.27","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03759-9"},{"key":"2025112811500643000_3.4.e100279.28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2024.101185","article-title":"Lipid metabolism in MASLD and MASH: From mechanism to the clinic","volume":"6","author":"Carli","year":"2024","journal-title":"JHEP Rep"},{"key":"2025112811500643000_3.4.e100279.29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/antiox11010086","article-title":"Cell Models and Omics Techniques for the Study of Nonalcoholic Fatty Liver Disease: Focusing on Stem Cell-Derived Cell Models","volume":"11","author":"Pelech\u00e1","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"2025112811500643000_3.4.e100279.30","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-020-10121-2"},{"key":"2025112811500643000_3.4.e100279.31","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202149641","article-title":"The \u201cDomino effect\u201d in MASLD: The inflammatory cascade of steatohepatitis","volume":"54","author":"Mladeni\u0107","year":"2024","journal-title":"Eur J Immunol"},{"key":"2025112811500643000_3.4.e100279.32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076248"},{"key":"2025112811500643000_3.4.e100279.33","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100939R","article-title":"Novel approaches to intervene gut microbiota in the treatment of chronic liver diseases","volume":"35","author":"Liu","year":"2021","journal-title":"FASEB J"},{"key":"2025112811500643000_3.4.e100279.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2024.05.003"},{"key":"2025112811500643000_3.4.e100279.35","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1160053","article-title":"An update on animal models of liver fibrosis","volume":"10","author":"Wu","year":"2023","journal-title":"Front Med"},{"key":"2025112811500643000_3.4.e100279.36","doi-asserted-by":"crossref","first-page":"123804","DOI":"10.1016\/j.ijbiomac.2023.123804","article-title":"The anti-toxic effect of the date palm fruit extract loaded on chitosan nanoparticles against CCl4-induced liver fibrosis in a mouse model","volume":"235","author":"Sahyon","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"2025112811500643000_3.4.e100279.37","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-00372-7"},{"key":"2025112811500643000_3.4.e100279.38","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000083","article-title":"Hyaluronan in liver fibrosis: basic mechanisms, clinical implications, and therapeutic targets","volume":"7","author":"Kim","year":"2023","journal-title":"Hepatol Commun"},{"key":"2025112811500643000_3.4.e100279.39","doi-asserted-by":"crossref","unstructured":"Di Fazio P , Mielke S , B\u00f6hm IT , et al . n.d. Toll-like receptor 5 tunes hepatic and pancreatic stellate cells activation. BMJ Open Gastroenterol:e001148. doi:10.1136\/bmjgast-2023-001148","DOI":"10.1136\/bmjgast-2023-001148"},{"key":"2025112811500643000_3.4.e100279.40","doi-asserted-by":"publisher","DOI":"10.1113\/JP281061"},{"key":"2025112811500643000_3.4.e100279.41","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.02.033"},{"key":"2025112811500643000_3.4.e100279.42","doi-asserted-by":"crossref","first-page":"127994","DOI":"10.1016\/j.bmcl.2021.127994","article-title":"Synthesis and anti-fibrotic effects of santamarin derivatives as cytotoxic agents against hepatic stellate cell line LX2","volume":"41","author":"Wang","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"key":"2025112811500643000_3.4.e100279.43","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27010330","article-title":"Evaluation of Substituted Pyrazole-Based Kinase Inhibitors in One Decade (2011-2020): Current Status and Future Prospects","volume":"27","author":"El-Gamal","year":"2022","journal-title":"Molecules"},{"key":"2025112811500643000_3.4.e100279.44","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/bit.28333","article-title":"In vitro modeling of liver fibrosis with 3D co-culture system using a novel human hepatic stellate cell line","volume":"120","author":"Lee","year":"2023","journal-title":"Biotechnol Bioeng"},{"key":"2025112811500643000_3.4.e100279.45","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.cmet.2024.04.003","article-title":"TM7SF3 controls TEAD1 splicing to prevent MASH-induced liver fibrosis","volume":"36","author":"Isaac","year":"2024","journal-title":"Cell Metab"},{"key":"2025112811500643000_3.4.e100279.46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jhep.2025.02.039","article-title":"Hot and cold fibrosis: The role of serum biomarkers to assess immune mechanisms and ECM-cell interactions in human fibrosis","volume":"83","author":"de Zawadzki","year":"2025","journal-title":"J Hepatol"},{"key":"2025112811500643000_3.4.e100279.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2021.10.002"},{"key":"2025112811500643000_3.4.e100279.48","first-page":"80","article-title":"Developing tissue engineering strategies for liver regeneration","volume":"3","author":"Wang","year":"2022","journal-title":"Eng Regen"},{"key":"2025112811500643000_3.4.e100279.49","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13194936","article-title":"Optimization and Validation of a Novel Three-Dimensional Co-Culture System in Decellularized Human Liver Scaffold for the Study of Liver Fibrosis and Cancer","volume":"13","author":"Thanapirom","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2025112811500643000_3.4.e100279.50","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70224","article-title":"Spatial\u2012temporal heterogeneities of liver cancer and the discovery of the invasive zone","volume":"15","author":"Yan","year":"2025","journal-title":"Clin Transl Med"},{"key":"2025112811500643000_3.4.e100279.51","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.7150\/ijms.46686","article-title":"Comprehensive comparison of patient-derived xenograft models in Hepatocellular Carcinoma and metastatic Liver Cancer","volume":"17","author":"Xu","year":"2020","journal-title":"Int J Med Sci"},{"key":"2025112811500643000_3.4.e100279.52","doi-asserted-by":"publisher","DOI":"10.21873\/cgp.20445"},{"key":"2025112811500643000_3.4.e100279.53","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13122970","article-title":"In Vitro 3D Cultures to Model the Tumor Microenvironment","volume":"13","author":"Fontana","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2025112811500643000_3.4.e100279.54","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054529","article-title":"Liver Organoids as an In Vitro Model to Study Primary Liver Cancer","volume":"24","author":"De Siervi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2025112811500643000_3.4.e100279.55","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00383-9"},{"key":"2025112811500643000_3.4.e100279.56","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14010226","article-title":"Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy","volume":"14","author":"Arvanitakis","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2025112811500643000_3.4.e100279.57","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13040730","article-title":"Inflammatory Mechanisms Underlying Nonalcoholic Steatohepatitis and the Transition to Hepatocellular Carcinoma","volume":"13","author":"Peiseler","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2025112811500643000_3.4.e100279.58","doi-asserted-by":"crossref","DOI":"10.1186\/s12938-024-01226-y","article-title":"Construction of in vitro liver-on-a-chip models and application progress","volume":"23","author":"Liu","year":"2024","journal-title":"Biomed Eng Online"},{"key":"2025112811500643000_3.4.e100279.59","first-page":"792","article-title":"Mitochondria at the Crossroads of Cholestatic Liver Injury: Targeting Novel Therapeutic Avenues","volume":"12","author":"Li","year":"2024","journal-title":"J Clin Transl Hepatol"},{"key":"2025112811500643000_3.4.e100279.60","doi-asserted-by":"crossref","first-page":"174447","DOI":"10.1016\/j.ejphar.2021.174447","article-title":"Advances of natural activators for Nrf2 signaling pathway on cholestatic liver injury protection: a review","volume":"910","author":"He","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"2025112811500643000_3.4.e100279.61","doi-asserted-by":"crossref","unstructured":"Xu Q . Human Three-Dimensional Hepatic Models: Cell Type Variety and Corresponding Applications. Front Bioeng Biotechnol 2021;9. doi:10.3389\/fbioe.2021.730008","DOI":"10.3389\/fbioe.2021.730008"},{"key":"2025112811500643000_3.4.e100279.62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0303786","article-title":"Comparing animal well-being between bile duct ligation models","volume":"19","author":"Tang","year":"2024","journal-title":"PLoS ONE"},{"key":"2025112811500643000_3.4.e100279.63","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2024.153829","article-title":"A 3D spheroid model of quadruple cell co-culture with improved liver functions for hepatotoxicity prediction","volume":"505","author":"Sun","year":"2024","journal-title":"Toxicology"},{"key":"2025112811500643000_3.4.e100279.64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.06.021"},{"key":"2025112811500643000_3.4.e100279.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.02.014"},{"key":"2025112811500643000_3.4.e100279.66","doi-asserted-by":"crossref","first-page":"104093","DOI":"10.1016\/j.etap.2023.104093","article-title":"Molecular mechanisms in thioacetamide-induced acute and chronic liver injury models","volume":"99","author":"Ezhilarasan","year":"2023","journal-title":"Environ Toxicol Pharmacol"},{"key":"2025112811500643000_3.4.e100279.67","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1486856","article-title":"In vitro, in vivo, and in silico approaches for evaluating the preclinical DMPK profiles of ammoxetine, a novel chiral serotonin and norepinephrine reuptake inhibitor","volume":"15","author":"Zhu","year":"2024","journal-title":"Front Pharmacol"},{"key":"2025112811500643000_3.4.e100279.68","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jhep.2024.04.026","article-title":"Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network","volume":"81","author":"Segovia-Zafra","year":"2024","journal-title":"J Hepatol"},{"key":"2025112811500643000_3.4.e100279.69","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jhep.2023.01.019","article-title":"A human liver organoid screening platform for DILI risk prediction","volume":"78","author":"Zhang","year":"2023","journal-title":"J Hepatol"},{"key":"2025112811500643000_3.4.e100279.70","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev-pathmechdis-051122-094016","article-title":"Acetaminophen Hepatotoxicity: Paradigm for Understanding Mechanisms of Drug-Induced Liver Injury","volume":"19","author":"Jaeschke","year":"2024","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"2025112811500643000_3.4.e100279.71","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/toxsci\/kfae133","article-title":"Limitations of acetaminophen as a reference hepatotoxin for the evaluation of in vitro liver models","volume":"203","author":"Livoti","year":"2025","journal-title":"Toxicol Sci"},{"key":"2025112811500643000_3.4.e100279.72","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1007\/s00204-024-03833-z","article-title":"Uncovering the mechanism of troglitazone-mediated idiosyncratic drug-induced liver injury with individual-centric models","volume":"98","author":"Roux","year":"2024","journal-title":"Arch Toxicol"},{"key":"2025112811500643000_3.4.e100279.73","doi-asserted-by":"publisher","DOI":"10.3389\/fddsv.2025.1536756"},{"key":"2025112811500643000_3.4.e100279.74","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-020-02937-6"},{"key":"2025112811500643000_3.4.e100279.75","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-53533-6","article-title":"Structural basis for hepatitis B virus restriction by a viral receptor homologue","volume":"15","author":"Shionoya","year":"2024","journal-title":"Nat Commun"},{"key":"2025112811500643000_3.4.e100279.76","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.210320","article-title":"Modelling T-cell immunity against hepatitis C virus with liver organoids in a microfluidic coculture system","volume":"12","author":"Natarajan","year":"2022","journal-title":"Open Biol"},{"key":"2025112811500643000_3.4.e100279.77","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000506","article-title":"Long-term HBV infection of engineered cultures of induced pluripotent stem cell-derived hepatocytes","volume":"8","author":"Yuan","year":"2024","journal-title":"Hepatol Commun"},{"key":"2025112811500643000_3.4.e100279.78","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1097\/HEP.0000000000000343","article-title":"Human liver organoids: From generation to applications","volume":"79","author":"Afonso","year":"2024","journal-title":"Hepatology"},{"key":"2025112811500643000_3.4.e100279.79","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-024-07070-z","article-title":"Precision-cut liver slices as an ex vivo model to assess impaired hepatic glucose production","volume":"7","author":"Kiyuna","year":"2024","journal-title":"Commun Biol"},{"key":"2025112811500643000_3.4.e100279.80","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jcmgh.2023.01.014","article-title":"Modeling Nonalcoholic Fatty Liver Disease in the Dish Using Human-Specific Platforms: Strategies and Limitations","volume":"15","author":"Rezvani","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2025112811500643000_3.4.e100279.81","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22137137","article-title":"Best Practices and Progress in Precision-Cut Liver Slice Cultures","volume":"22","author":"Dewyse","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025112811500643000_3.4.e100279.82","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000558","article-title":"Precision-cut liver slices as an ex vivo model to evaluate antifibrotic therapies for liver fibrosis and cirrhosis","volume":"8","author":"Wang","year":"2024","journal-title":"Hepatol Commun"},{"key":"2025112811500643000_3.4.e100279.83","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000706","article-title":"Precision-cut tumor slices for modeling hepatocellular carcinoma enable at-scale drug screening","volume":"9","author":"Collins","year":"2025","journal-title":"Hepatol Commun"},{"key":"2025112811500643000_3.4.e100279.84","doi-asserted-by":"crossref","first-page":"107867","DOI":"10.1016\/j.pharmthera.2021.107867","article-title":"The pathophysiological function of non-gastrointestinal farnesoid X receptor","volume":"226","author":"Yan","year":"2021","journal-title":"Pharmacol Ther"},{"key":"2025112811500643000_3.4.e100279.85","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104826","article-title":"Patient-derived precision cut tissue slices from primary liver cancer as a potential platform for preclinical drug testing","volume":"97","author":"Jagatia","year":"2023","journal-title":"EBioMedicine"},{"key":"2025112811500643000_3.4.e100279.86","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26062658","article-title":"Decoding Liver Fibrosis: How Omics Technologies and Innovative Modeling Can Guide Precision Medicine","volume":"26","author":"Codotto","year":"2025","journal-title":"Int J Mol Sci"},{"key":"2025112811500643000_3.4.e100279.87","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.tibtech.2019.12.010","article-title":"Bioengineered 3D Models to Recapitulate Tissue Fibrosis","volume":"38","author":"Sacchi","year":"2020","journal-title":"Trends Biotechnol"},{"key":"2025112811500643000_3.4.e100279.88","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40883-019-00131-4","article-title":"Liver Cryopreservation for Regenerative Medicine Applications","volume":"7","author":"Sharma","year":"2021","journal-title":"Regen Eng Transl Med"},{"key":"2025112811500643000_3.4.e100279.89","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.686088","article-title":"Use of Precision-Cut Tissue Slices as a Translational Model to Study Host-Pathogen Interaction","volume":"8","author":"Majorova","year":"2021","journal-title":"Front Vet Sci"},{"key":"2025112811500643000_3.4.e100279.90","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s44272-024-00012-0","article-title":"Progress, application and challenges of liver organoids","volume":"3","author":"Sang","year":"2024","journal-title":"CCB"},{"key":"2025112811500643000_3.4.e100279.91","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10565-020-09544-2","article-title":"Human hepatic in vitro models reveal distinct anti-NASH potencies of PPAR agonists","volume":"37","author":"Boeckmans","year":"2021","journal-title":"Cell Biol Toxicol"},{"key":"2025112811500643000_3.4.e100279.92","doi-asserted-by":"crossref","unstructured":"Wang L , Riediger L , Rao Q , et al . Tunable Synthetic Hydrogel Modulates Hepatic Lineage Specification of Human Liver Organoid. Adv Funct Mater 2025.:e08430. doi:10.1002\/adfm.202508430","DOI":"10.1002\/adfm.202508430"},{"key":"2025112811500643000_3.4.e100279.93","doi-asserted-by":"crossref","first-page":"100198","DOI":"10.1016\/j.jhepr.2020.100198","article-title":"Organoids to model liver disease","volume":"3","author":"Nuciforo","year":"2021","journal-title":"JHEP Reports"},{"key":"2025112811500643000_3.4.e100279.94","doi-asserted-by":"crossref","first-page":"122360","DOI":"10.1016\/j.biomaterials.2023.122360","article-title":"Human chemically-derived hepatic progenitors (hCdHs) as a source of liver organoid generation: Application in regenerative medicine, disease modeling, and toxicology testing","volume":"303","author":"Salas-Silva","year":"2023","journal-title":"Biomaterials"},{"key":"2025112811500643000_3.4.e100279.95","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/jmcb\/mjaa013","article-title":"Progress in human liver organoids","volume":"12","author":"Sun","year":"2020","journal-title":"J Mol Cell Biol"},{"key":"2025112811500643000_3.4.e100279.96","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13287-023-03235-5","article-title":"Generation of multilineage liver organoids with luminal vasculature and bile ducts from human pluripotent stem cells via modulation of Notch signaling","volume":"14","author":"Kim","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"2025112811500643000_3.4.e100279.97","doi-asserted-by":"crossref","first-page":"122898","DOI":"10.1016\/j.biomaterials.2024.122898","article-title":"Optimization of culture conditions to generate vascularized multi-lineage liver organoids with structural complexity and functionality","volume":"314","author":"Chi","year":"2025","journal-title":"Biomaterials"},{"key":"2025112811500643000_3.4.e100279.98","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2023.105728"},{"key":"2025112811500643000_3.4.e100279.99","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113918"},{"key":"2025112811500643000_3.4.e100279.100","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-08850-1"},{"key":"2025112811500643000_3.4.e100279.101","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/s41551-025-01416-6","article-title":"Self-organization of sinusoidal vessels in pluripotent stem cell-derived human liver bud organoids","volume":"9","author":"Saiki","year":"2025","journal-title":"Nat Biomed Eng"},{"key":"2025112811500643000_3.4.e100279.102","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaz6964"},{"key":"2025112811500643000_3.4.e100279.103","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.12.012"},{"key":"2025112811500643000_3.4.e100279.104","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00595-020-02092-6","article-title":"Current status of hepatocyte-like cell therapy from stem cells","volume":"51","author":"Saito","year":"2021","journal-title":"Surg Today"},{"key":"2025112811500643000_3.4.e100279.105","doi-asserted-by":"crossref","DOI":"10.1038\/s41597-023-02001-9","article-title":"A dataset of definitive endoderm and hepatocyte differentiations from human induced pluripotent stem cells","volume":"10","author":"Tanaka","year":"2023","journal-title":"Sci Data"},{"key":"2025112811500643000_3.4.e100279.106","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/cells10010126","article-title":"Effect of Microbial Short-Chain Fatty Acids on CYP3A4-Mediated Metabolic Activation of Human Pluripotent Stem Cell-Derived Liver Organoids","volume":"10","author":"Mun","year":"2021","journal-title":"Cells"},{"key":"2025112811500643000_3.4.e100279.107","doi-asserted-by":"crossref","first-page":"508","DOI":"10.7150\/ijms.83973","article-title":"Role of connexin 32 in the directional differentiation of induced pluripotent stem cells into hepatocytes","volume":"21","author":"Xu","year":"2024","journal-title":"Int J Med Sci"},{"key":"2025112811500643000_3.4.e100279.108","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1038\/s41467-025-57551-w","article-title":"Placenta-derived factors contribute to human iPSC-liver organoid growth","volume":"16","author":"Kuse","year":"2025","journal-title":"Nat Commun"},{"key":"2025112811500643000_3.4.e100279.109","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s44222-022-00013-5","article-title":"CRISPR engineering in organoids for gene repair and disease modelling","volume":"1","author":"Geurts","year":"2023","journal-title":"Nat Rev Bioeng"},{"key":"2025112811500643000_3.4.e100279.110","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-01680-4"},{"key":"2025112811500643000_3.4.e100279.111","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.omtm.2023.08.003","article-title":"Establishment of UGT1A1-knockout human iPS-derived hepatic organoids for UGT1A1-specific kinetics and toxicity evaluation","volume":"30","author":"Shintani","year":"2023","journal-title":"Mol Ther Methods Clin Dev"},{"key":"2025112811500643000_3.4.e100279.112","doi-asserted-by":"crossref","unstructured":"Hidalgo-\u00c1lvarez J , Fonseca TL , Salas-Lucia F , et al . Integrative Protocol for Generation of iPSC-Derived 3D Human Hepatic Organoids. J Vis Exp 2024;214. doi:10.3791\/67070","DOI":"10.3791\/67070"},{"key":"2025112811500643000_3.4.e100279.113","article-title":"CRISPR\/Cas9-mediated Precise SNP Editing in Human iPSC Lines","volume":"11","author":"Zhang","year":"2021","journal-title":"Bio Protoc"},{"key":"2025112811500643000_3.4.e100279.114","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.09.031"},{"key":"2025112811500643000_3.4.e100279.115","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0414-6"},{"key":"2025112811500643000_3.4.e100279.116","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00346.2021"},{"key":"2025112811500643000_3.4.e100279.117","doi-asserted-by":"crossref","first-page":"123262","DOI":"10.1016\/j.talanta.2022.123262","article-title":"Design and fabrication of an integrated 3D dynamic multicellular liver-on-a-chip and its application in hepatotoxicity screening","volume":"241","author":"Zheng","year":"2022","journal-title":"Talanta"},{"key":"2025112811500643000_3.4.e100279.118","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2021.07.013"},{"key":"2025112811500643000_3.4.e100279.119","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s43856-022-00209-1","article-title":"Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology","volume":"2","author":"Ewart","year":"2022","journal-title":"Commun Med"},{"key":"2025112811500643000_3.4.e100279.120","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1111\/liv.14942","article-title":"Experimental liver models: From cell culture techniques to microfluidic organs\u2010on\u2010chip","volume":"41","author":"Polidoro","year":"2021","journal-title":"Liver Int"},{"key":"2025112811500643000_3.4.e100279.121","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2015.08.043"},{"key":"2025112811500643000_3.4.e100279.122","doi-asserted-by":"crossref","DOI":"10.1186\/s41232-022-00248-0","article-title":"State-of-the-art liver disease research using liver-on-a-chip","volume":"42","author":"Deguchi","year":"2022","journal-title":"Inflamm Regen"},{"key":"2025112811500643000_3.4.e100279.123","doi-asserted-by":"crossref","first-page":"2403516","DOI":"10.1002\/advs.202403516","article-title":"Dissecting Acute Drug\u2010Induced Hepatotoxicity and Therapeutic Responses of Steatotic Liver Disease Using Primary Mouse Liver and Blood Cells in a Liver\u2010On\u2010A\u2010Chip Model","volume":"11","author":"Liu","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"2025112811500643000_3.4.e100279.124","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-334425"},{"key":"2025112811500643000_3.4.e100279.125","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13104-023-06575-w","article-title":"Functional integration of natural killer cells in a microfluidically perfused liver on-a-chip model","volume":"16","author":"Fahrner","year":"2023","journal-title":"BMC Res Notes"},{"key":"2025112811500643000_3.4.e100279.126","doi-asserted-by":"crossref","first-page":"100025","DOI":"10.1016\/j.amolm.2023.100025","article-title":"Isogenic hiPSC-derived liver-on-chip platforms: A valuable tool for modeling metabolic liver diseases","volume":"2","author":"Aina","year":"2023","journal-title":"Asp Mol Med"},{"key":"2025112811500643000_3.4.e100279.127","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/hep.30918","article-title":"A Bile Duct-on-a-Chip With Organ-Level Functions","volume":"71","author":"Du","year":"2020","journal-title":"Hepatology"},{"key":"2025112811500643000_3.4.e100279.128","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.478","article-title":"Co-Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate\u00ae Liver-Chip for the Study of Drug-Induced Liver Injury","volume":"2","author":"Shi","year":"2022","journal-title":"Curr Protoc"},{"key":"2025112811500643000_3.4.e100279.129","doi-asserted-by":"crossref","first-page":"2406573","DOI":"10.1002\/advs.202406573","article-title":"Biomimetic Liver Lobules from Multi\u2010Compartmental Microfluidics","volume":"11","author":"Huang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"2025112811500643000_3.4.e100279.130","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-44198-0","article-title":"A model of hepatic steatosis with declined viability and function in a liver-organ-on-a-chip","volume":"13","author":"Wiriyakulsit","year":"2023","journal-title":"Sci Rep"},{"key":"2025112811500643000_3.4.e100279.131","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109393"},{"key":"2025112811500643000_3.4.e100279.132","doi-asserted-by":"crossref","first-page":"16280","DOI":"10.1021\/acs.analchem.4c03234","article-title":"Dynamic Liver Chip Based on Well-Coupled Microfluidics: An Accurate NASH Model for Drug Evaluation","volume":"96","author":"Chang","year":"2024","journal-title":"Anal Chem"},{"key":"2025112811500643000_3.4.e100279.133","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13619-025-00226-0","article-title":"Standard: human liver-on-a-chip","volume":"14","author":"Liu","year":"2025","journal-title":"Cell Regen"},{"key":"2025112811500643000_3.4.e100279.134","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s42003-023-04710-8","article-title":"Integrated-gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease","volume":"6","author":"Yang","year":"2023","journal-title":"Commun Biol"},{"key":"2025112811500643000_3.4.e100279.135","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1021\/acsbiomaterials.1c00642","article-title":"Usability of Polydimethylsiloxane-Based Microfluidic Devices in Pharmaceutical Research Using Human Hepatocytes","volume":"7","author":"Deguchi","year":"2021","journal-title":"ACS Biomater Sci Eng"},{"key":"2025112811500643000_3.4.e100279.136","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1021\/acsbiomaterials.7b00417","article-title":"Liver-Kidney-on-Chip To Study Toxicity of Drug Metabolites","volume":"4","author":"Theobald","year":"2018","journal-title":"ACS Biomater Sci Eng"},{"key":"2025112811500643000_3.4.e100279.137","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1021\/acsabm.2c00041","article-title":"Advances in Organ-on-a-Chip Materials and Devices","volume":"5","author":"Nahak","year":"2022","journal-title":"ACS Appl Bio Mater"},{"key":"2025112811500643000_3.4.e100279.138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41378-023-00544-w","article-title":"Microneedle array facilitates hepatic sinusoid construction in a large-scale liver-acinus-chip microsystem","volume":"9","author":"Li","year":"2023","journal-title":"Microsyst Nanoeng"},{"key":"2025112811500643000_3.4.e100279.139","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101808","article-title":"An In Vitro Whole-Organ Liver Engineering for Testing of Genetic Therapies","volume":"23","author":"Lorvellec","year":"2020","journal-title":"iScience"},{"key":"2025112811500643000_3.4.e100279.140","doi-asserted-by":"crossref","first-page":"100004","DOI":"10.1124\/dmd.124.001497","article-title":"Utilization of a human Liver Tissue Chip for drug-metabolizing enzyme induction studies of perpetrator and victim drugs","volume":"53","author":"Ohri","year":"2025","journal-title":"Drug Metab Dispos"},{"key":"2025112811500643000_3.4.e100279.141","doi-asserted-by":"crossref","first-page":"114292","DOI":"10.1016\/j.colsurfb.2024.114292","article-title":"Convenient rapid prototyping microphysiological niche for mimicking liver native basement membrane: Liver sinusoid on a chip","volume":"245","author":"Ebrahimi","year":"2025","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2025112811500643000_3.4.e100279.142","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax5516","article-title":"Reproducing human and cross-species drug toxicities using a Liver-Chip","volume":"11","author":"Jang","year":"2019","journal-title":"Sci Transl Med"},{"key":"2025112811500643000_3.4.e100279.143","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202403560","article-title":"Liver-on-a-Chip Integrated with Label-Free Optical Biosensors for Rapid and Continuous Monitoring of Drug-Induced Toxicity","volume":"20","author":"Yang","year":"2024","journal-title":"Small"},{"key":"2025112811500643000_3.4.e100279.144","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtbio.2024.101143","article-title":"Liver-on-chips for drug discovery and development","volume":"27","author":"Mehta","year":"2024","journal-title":"Mater Today Bio"}],"container-title":["eGastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/egastro-2025-100279","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T19:50:23Z","timestamp":1764359423000},"score":1,"resource":{"primary":{"URL":"http:\/\/egastroenterology.bmj.com\/lookup\/doi\/10.1136\/egastro-2025-100279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":144,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,11,28]]},"published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1136\/egastro-2025-100279"],"URL":"https:\/\/doi.org\/10.1136\/egastro-2025-100279","relation":{},"ISSN":["2766-0125","2976-7296"],"issn-type":[{"value":"2766-0125","type":"print"},{"value":"2976-7296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}